GET THE APP

The role of echocardiography in hypertension
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

The role of echocardiography in hypertension


11th Annual Cardiology Summit

September 12-13, 2016 Philadelphia, USA

Sibel Catirli Enar

Istanbul University, Turkey

Scientific Tracks Abstracts: J Clin Exp Cardiolog

Abstract :

Systemic hypertension causes hypertensive heart disease. Chronic systemic pressure loading results in left ventricular hypertrophy in order to maintain normal wall stress. In earlier stages of hypertension, systolic function is preserved. But in later stages or with concomitant coronary artery disease, systolic function is also impaired. The echocardiographic findings related with hypertension are as follows: Left ventricular hypertrophy (LVH), left atrial (LA) dilatation, diastolic dysfunction, systolic dysfunction, mitral annular calcification, aortic sclerosis and aortic root dilatation. LVH is symmetrical in hypertension. ASE/EAE guidelines and cut off limits for LVH: LV septal wall thickness >0.9 cm for women and >1.0 cm for men. Mild LVH: LV septal thickness 1.0-1.2 cm/1.1-1.3 cm. Moderate LVH: 1.3-1.5/1.4-1.5 cm. Severe LVH: >1.6/>1.7 cm. Left ventricular hypertrophy causes different changes in longitudinal, radial and circumferential mechanics in patients with hypertensive patients. Longitudinal strain is significantly decreased, while radial strain is increased. Left atrial dilatation is commonly seen in hypertensive patients. Left atrial dilation is related to diastolic dysfunction. Left atrial size is also a predictor of paroxysmal atrial fibrillation in hypertensive patients. Recent studies have shown that measurement of left atrial strain with speckle tracking may be useful in determining left atrial functioning hypertensive patients. According to the studies, it has been shown that LA strain values are lower in hypertensive patients when compared to normal, irrespective to the presence of LA enlargement or LVH. Decrease in SR values is present in all three phases of LA function. Reason for LA dysfunction in hypertensive patients is explained by the chronic pressure exposure of the LA, LA pressure rise and reduction of reservoir and conduit functions. In the earliest stages of the disease, systolic function is preserved unless coronary artery disease accompanies. Small, hypertrophic left ventricle is typical for this form of the disease. However, recent studies using 2D speckle tracking strain demonstrate that impaired myocardial systolic deformation occurs in hypertensive patients. Therefore, systolic left ventricular longitudinal strain decreases in the early stages of left ventricular remodeling. Mitral annular calcification is frequently seen in chronic hypertensive patients. It is the reason for mild or moderate mitral regurgitation in these patients. Measures of right ventricular deformation are reduced in patients with LVH secondary to hypertension. So, LVH may cause early sub clinical RV dysfunction as well. According to the most recent guidelines, it is stated that initiation or monitoring the response to antihypertensive response is based on clinical parameters. However, periodic evaluation of cardiac function and morphology by echocardiography are necessary because of the progressive characteristics of hypertensive cardiomyopathy.

Biography :

Sibel Catirli Enar has completed her MD degree from Istanbul University in 1981. She has become Anaesthesiology Specialist in the year 1985 and Cardiology Specialist in 1992 after completing her education in Istanbul University and Institute of Cardiology (Istanbul University). She is an Associate Professor of Cardiology, FESC and FASE. She is working at Turkiye Hospital and Istanbul Memorial Hospital. She is a member of Cardiac Societies, involved in multicenter trials, and has served as a Speaker, Moderator and Abstract Grader at various national and international conferences. She has published more than 25 papers and has contributed to book chapters. She is also serving as an Associate Member at the Board of Turkish Society of Cardiology (for 2016-2018).

Email: [email protected]

Top